Compare ARK Genomic Revolution ETF (ARKG) vs American States Water Company (AWR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs American States Water Company — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while American States Water Company trades at $84.94 (market cap $3.31B). The key difference: American States Water Company pays a 2.39% dividend while ARK Genomic Revolution ETF pays none, and American States Water Company is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | AWR | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $84.76 |
52-Week Low | $23.09 | $70.10 |
Market Cap | — | $3.31B |
Enterprise Value | — | $4.22B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
American States Water (AWR) trades at $84.51, up 0.78% today, with a bullish technical outlook supported by moving averages and strong momentum indicators. The company reported solid 2025 results with $658M revenue and $130M net income, maintaining a robust 19.66% net margin. Recent news highlights its inclusion in TIME's America's Best Companies 2026 list and a completed $200M equity offering, reinforcing its stable utility model and 71-year dividend growth streak.
AWR offers defensive appeal with reliable dividends and infrastructure investments, but faces execution risks from regulatory approvals and interest rate sensitivity. Analyst consensus is mixed with 20% buy ratings, reflecting cautious optimism amid recent earnings misses. The stock's premium valuation (P/E 24.64) requires sustained growth to justify upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About American States Water Company
American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.
Read more on AWR →
